J Stephenson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useBenzamidesCetuximabClinical Trials as TopicEnzyme Inhibitors/therapeutic useGastrointestinal Neoplasms/drug therapyHumansImatinib MesylateMedical Oncology/trendsNeoplasms/drug therapyNeoplasms/enzymologyNeoplasms/geneticsPiperazines/therapeutic usePyrimidines/therapeutic useReceptor Protein-Tyrosine Kinases/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBenzamidesEnzyme InhibitorsPiperazinesPyrimidinesImatinib MesylateReceptor Protein-Tyrosine KinasesCetuximab
Year: 2001 PMID: 11401587 DOI: 10.1001/jama.285.22.2841
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272